Company

Company

History

  • 2013.12

    Developed CellSquare: Liquid-based Cytology Device

    2013.11

    Developed GynPad: Self-collection kit for HPV/STI

    2013.11

    Published article: cfDNA as cancer biomarker
    (with Chaum hosp., Seoul medical center and Miz Medi hosp.)

    2012.07

    Presentation on TCM's cancer methylation research
    at Wonca 2012(global family doctor association)
    (Miz Medi Dr. Kim, Kyoung-Chul)

    2010.10

    Developed/implemented
    HPV, STI multiplexed test

    2009.9

    Developed/implemented simultaneous test for
    Avian, novel and seasonal influenza A/B

    2009.8

    Started Bioengineering Dept.
    based on developed multiplexing Tech.
    Founded TCM Korea Inc.

  • 2014.12

    Acquired Office Space in Pangyo, Techno Valley
    (current HQ building)

    2014.11

    CellSquare®: acquired KGMP (KFDA)

    2014.09

    Certified medical device manufacturer (KFDA)

    2014.08

    Co-research on breast cancer: circulating cfDNA
    (with Seoul National Univ. hospital in Bundang)

    2014.06

    Co-research on Mitochondrial DNA copy number and
    hormones in men with metabolic syndrome
    (with Yonsei Univ. hosp.)

    2014.04

    Established TCM Biomedical Engineering Center
    (Certified affiliated research institute)

    2014.02

    Certified Venture comapany

  • 2015.10.22

    Listed on KONEX exchange

    2015.09

    Co-research on Gastric Cancer and cfDNA
    Presented result on Molecular & Clinical Oncology
    (with Chaum hosp.)

    2015.08

    CellSquare®: CE, FCC certification

    2015.07

    Moved HQ
    to Pangyo Company Building

    2015.05

    CellSquare®: listed US FDA
    approved medical device

  • 2016.11

    GynPad®: Approved medical device
    (KFDA)

    2016.06

    Certified foreign invested company:
    from D'allah group of Saudi Arabia

    2016.04

    Expansion on Medical Department:
    GynPad®: Certified KGMP (KFDA)

    2016.02

    Certified: ISO 9001, 13485

    2016.01

    Certified: Inno-Biz

  • 2017.03.29

    TCM Korea Inc. Changed the name to
    TCM Biosciences Inc.

    2017.03

    Strategic investment in BioReaders
    (KOSDAQ)

    2017.01

    GynPad® Certified medical device
    (KFDA)